哈三聯(002900.SZ)子公司變更經營範圍 涉及甲醇/乙酸乙酯(3:1)、四氫呋喃等
格隆匯4月15日丨哈三聯(002900.SZ)公佈,公司收到全資子公司蘭西哈三聯製藥有限公司的通知,其對經營範圍進行了變更,並已完成工商變更登記手續,取得了蘭西縣市場監督管理局換髮的《營業執照》。具體變更情況如下:
變更前:
經營範圍:大容量注射劑、原料藥、貼膏劑(凝膠貼膏),單位自有房屋租賃服務,醫藥設備租賃服務、生物工程技術開發、藥學研究服務,化學藥品原料的研發、製造、銷售;多層共擠膜輸液用袋(國家禁止的除外)生產、銷售。(依法須經批准的項目,經相關部門批准後方可開展經營活動)
變更後:
經營範圍:甲醇/乙酸乙酯(3:1)、四氫呋喃、乙醇、甲醇(危險品經營許可證有效期至2023年4月7日)銷售;大容量注射劑、原料藥、貼膏劑(凝膠貼膏)、片劑、硬膠囊劑生產、銷售;單位自有房屋租賃服務,醫藥設備租賃服務、生物工程技術開發、藥學研究服務,化學藥品原料的研發、製造、銷售;多層共擠膜輸液用袋(國家禁止的除外)生產、銷售。(依法須經批准的項目,經相關部門批准後方可開展經營活動)
除經營範圍變更外,蘭西哈三聯製藥有限公司《營業執照》的其他登記事項均保持不變。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.